Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women

Clin Endocrinol (Oxf). 2011 Oct;75(4):464-9. doi: 10.1111/j.1365-2265.2011.04078.x.

Abstract

Objective: We examined the relationship between brachial-ankle pulse wave velocity (baPWV) reflecting arterial stiffness and the levels of novel hepatokines fibroblast growth factor 21 (FGF21) and fetuin-A. In addition, we evaluated the effect of a 3-month combined aerobic and resistance exercise programme on FGF21 and fetuin-A levels as well as arterial stiffness in obese women.

Methods: Forty nondiabetic, obese women (body mass index = 27·6 ± 2·4 kg/m(2) ) were included in the study and were compared before and after a 3-month exercise programme, which was composed of 45 min of aerobic exercise at an intensity of 60-75% of the age-predicted maximum heart rate (300 kcal/session) and 20 min of resistance training (100 kcal/session) five times a week. All exercise sessions were supervised by a professional exercise physiologist.

Results: At baseline, baPWV levels were correlated with age, body mass index (BMI), systolic blood pressure (SBP), high density lipoprotein cholesterol, fasting glucose and serum FGF21 levels. In a multiple stepwise regression analysis using baPWV as a dependent variable, baPWV levels were associated with age, BMI, SBP, FGF21 and fetuin-A levels (R(2) = 0·744). After the exercise programme, BMI, waist circumference, SBP, diastolic blood pressure and triglyceride levels were significantly decreased. Moreover, baPWV values were significantly improved (P < 0·001) along with modest decrease in FGF21 levels (P = 0·043). However, fetuin-A levels were not changed significantly (P = 0·202).

Conclusions: A 3-month combined exercise programme decreases the FGF21 levels as well as arterial stiffness in obese Korean women.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / metabolism
  • Body Mass Index
  • Cholesterol, LDL / blood
  • Enzyme-Linked Immunosorbent Assay
  • Exercise / physiology*
  • Female
  • Fibroblast Growth Factors / blood*
  • Humans
  • Middle Aged
  • Obesity / blood*
  • Obesity / metabolism*
  • alpha-2-HS-Glycoprotein / metabolism*

Substances

  • Blood Glucose
  • Cholesterol, LDL
  • alpha-2-HS-Glycoprotein
  • fibroblast growth factor 21
  • Fibroblast Growth Factors